WELLINGTON MANAGEMENT GROUP LLP - CADENCE PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 77 filers reported holding CADENCE PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 4.64 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of CADENCE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$46,632,000
+23.8%
5,152,679
-13.7%
0.01%
+8.3%
Q3 2013$37,659,000
-12.8%
5,968,146
-5.8%
0.01%
-14.3%
Q2 2013$43,204,000–6,334,921–0.01%–
 Download
Other shareholders

There were no reported owners of CADENCE PHARMACEUTICALS INC in Q2 2013.

NameSharesValueWeighting ↓
View complete list of CADENCE PHARMACEUTICALS INC shareholders